V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryHTA Licence
Compliance · The complete guide

HTA Licence: Human Tissue Authority Licensing Explained

In short

A practical guide to human tissue licensing frameworks, accountable roles and the records that support day-to-day oversight.

4,343 words · ~20 min read
HTA licence: a tissue bank technician in PPE checks labelled cryogenic storage racks on a tablet
An HTA licence authorises licensable activities with human tissue in the UK.
On this page
  1. 01What an HTA Licence authorises—and what to distinguish from it
  2. 02Map the framework by territory, material and intended use
  3. 03Identify the activity before deciding whether a licence is needed
  4. 04Assign the Designated Individual, licence holder and local support roles
  5. 05Turn licence conditions into a controlled evidence register
  6. 06Manage licensing as an operational lifecycle
  7. 07Connect licence scope, material movements and review evidence
  8. 08Prepare for inspection through evidence retrieval and operational checks
  9. 09Review licence changes and control operational shortfalls
  10. 10Three worked cases: premises, reconciliation and DI succession
  11. 11Use a final review checklist and the appropriate primary resources
On this page · 11 sections
  1. 1What an HTA Licence authorises—and what to distinguish from it
  2. 2Map the framework by territory, material and intended use
  3. 3Identify the activity before deciding whether a licence is needed
  4. 4Assign the Designated Individual, licence holder and local support roles
  5. 5Turn licence conditions into a controlled evidence register
  6. 6Manage licensing as an operational lifecycle
  7. 7Connect licence scope, material movements and review evidence
  8. 8Prepare for inspection through evidence retrieval and operational checks
  9. 9Review licence changes and control operational shortfalls
  10. 10Three worked cases: premises, reconciliation and DI succession
  11. 11Use a final review checklist and the appropriate primary resources
AI · Explain it for MY operation

How does HTA Licence apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What an HTA Licence authorises—and what to distinguish from it

An HTA Licence is an authorisation issued by the Human Tissue Authority for specified activities involving human tissue. The HTA licensing overview describes establishments storing and using tissue for purposes including patient treatment, organ transplantation, post-mortem examination, research, teaching and public exhibitions. This describes the licensing landscape, not a blanket rule that every use of human tissue requires a licence.

For operational planning, distinguish the external authorisation from the internal records and decisions used to organise work. The following comparison is a practical records model, not a list of additional licensing requirements.

TermQuestion it answersOperational use
HTA licenceWhat activities does the HTA authorise?Reference for the establishment’s authorised scope.
Internal scope assessmentHow does proposed work fit that scope?Records the assessment and questions needing resolution.
SOPHow should staff perform the task?Defines the internal working method.
Training recordWhat instruction or assessment has a person completed?Documents preparation for assigned work.
Internal disposition decisionWhat should happen to this material next?Records a human decision to use, transfer, retain or dispose of material.

The latter four are operational records or decisions, not alternative forms of HTA authorisation. In this model, the licence anchors scope; day-to-day records show how work was controlled. Attributable recording helps identify who performed or reviewed an action, while an audit trail supports review of record changes. Neither substitutes for the authorisation itself.

02Map the framework by territory, material and intended use

Start with the establishment’s location, the material handled and its intended use—not a single “UK tissue licence” assumption. The HTA’s legislation overview identifies the Human Tissue Act 2004 and the Human Tissue (Quality and Safety for Human Application) Regulations 2007 as distinct legislative frameworks. These are legislation; the HTA pages explain their application as official guidance.

According to HTA guidance on Human Tissue Act licensing, the Act principally covers England, Wales and Northern Ireland; only section 45 and schedule 4 include Scotland. The guidance identifies separate Scottish legislation, the Human Tissue (Scotland) Act 2006. That distinction does not, by itself, answer a Scottish establishment’s licensing question.

For activities involving tissues and cells for patient treatment—human application—the HTA’s explanation of the framework distinction points to licensing under the 2007 Q&S Regulations. This is a framework distinction, not an exhaustive test of which activities require a licence.

Territory or project contextMaterial and intended useFramework referenceScope question
England, Wales or Northern Ireland: Human Tissue Act activitiesHuman tissue; identify activity and purposeHuman Tissue Act 2004Does the proposed activity fall within the applicable licensing scope?
Scottish activitiesIdentify tissue, activity and intended useHuman Tissue (Scotland) Act 2006; stated 2004 Act qualificationWhich current provisions apply to this activity?
Human applicationTissues and cells for patient treatment2007 Q&S RegulationsCheck current applicable text for territorial coverage and activity scope.
Mixed manufacturing/research projectsSeparate materials, uses and process stagesAssess tissue frameworks and product rules separatelyCheck current applicable text for product-specific interfaces.

As a practical scoping method, pharma, device, supplement, food and chemical organisations should complete this matrix for the actual tissue activity rather than classify the project by company industry label. Keep finished-product authorisations and tissue licensing as separate assessment questions; use the MHRA overview to orient the product-side review where relevant. Record unresolved boundaries for specialist review instead of treating one authorisation as the answer to both questions.

03Identify the activity before deciding whether a licence is needed

The HTA's list of licensed activities covers, under the Human Tissue Act 2004: carrying out an anatomical examination; making a post-mortem examination; removal of relevant material from a deceased person; storage of relevant material from a deceased person (other than for a specific ethically approved project); storage of anatomical specimens; storage of relevant material from a living person for research (other than for a specific ethically approved project); and public display of a body or material from a deceased person. For human application, the licensed activities are procurement, testing, processing, storage, distribution, import and export of tissues and cells.

Territorial reach differs by regime. The HTA states that the Human Tissue Act 2004 covers England, Northern Ireland and Wales, while Scotland has its own Human Tissue (Scotland) Act 2006. The human-application Regulations of 2007 cover all four nations, so establishments in Scotland carrying out activities relating to tissues or cells for human application may require a licence from the HTA. Which activities an individual establishment needs licensed remains a case-by-case question for the HTA.

HTA guidance on Human Tissue Act licensing names the six broad activity categories below. These are activities, not six HTA sectors or an exhaustive licensing test. Start by describing each operation, rather than treating a department name such as “research” as the scope decision.

The second and third columns are practical assessment prompts, not statutory requirements. For every row, establish the material involved, what happens to it, the premises, its intended purpose and the person responsible for resolving uncertainty.

Activity categoryFacts to establishDecision to document
Anatomical examinationsBodies or specimens examined; examination steps, teaching or other purpose, and examination location.Examination activities assessed, premises included and named scope reviewer.
Post-mortem examinationsExamination purpose, material examined, procedures performed and locations used.Examination boundary, related activities needing separate assessment and responsible reviewer.
Tissue removal from deceased personsTissue removed, removal procedure and location, intended use and destination.Removal activity assessed, downstream questions and reviewer assigned to resolve them.
Storage for scheduled purposesMaterial held, storage locations, intended purposes and planned subsequent use.Storage activities and purposes included, unresolved classifications and accountable reviewer.
Storage of anatomical specimensSpecimens retained, storage premises, intended use and movements between locations.Specimens and storage operations assessed, boundaries and person resolving scope.
Public display of human remainsRemains displayed, presentation arrangements, venue and intended display purpose.Display activity and locations assessed, open questions and named reviewer.

For human-application projects, use the distinction covered above and consult HTA guidance on Q&S licensing for current scope questions rather than stretching this activity list to fit.

As an internal practice, write a scope decision recording assumptions, unresolved questions, the accountable reviewer and every activity included. Keep an internal assessment distinct from any determination received from the HTA: label each clearly and retain the relevant correspondence. An internal assessment organises the licensing question; it does not itself authorise the activity.

04Assign the Designated Individual, licence holder and local support roles

The Designated Individual (DI) is the person under whose supervision the licensed activity is authorised to be carried out, as described in HTA guidance on the Designated Individual. Establishment governance should make that supervision visible in operational decisions, rather than treating the role as a name on an organisation chart.

HTA guidance explaining section 18 identifies the DI’s primary legal responsibility to secure suitable practices, suitable people working under the licence, and compliance with licence conditions. These are statutory responsibilities described by the guidance; the evidence arrangements below are suggested practice, not additional legal requirements.

The licence holder has a distinct role: HTA guidance on licence holders states that the holder must have the DI’s prior consent to make the application. Operationally, keep a clear record of that consent and identify who coordinates application information.

A Person Designated (PD) can provide supplementary local support. HTA guidance on the Person Designated explains that this may include advising colleagues about procedures and systems agreed by the DI. The DI remains responsible for supervising the activities; local task allocation does not transfer that accountability.

A practical responsibility matrix

Use a matrix such as this to distinguish preparation from oversight. Assign named people and deputies to the suggested operational roles, without changing the responsibilities above.

TaskSuggested preparation or coordinationEvidence for DI oversight
Scope reviewsActivity leads describe current operations; licence-holder contact coordinates information.Activity summary with unresolved scope questions.
Staff suitability evidenceLine managers assemble role-specific assessments.Competence records, supervision arrangements and identified gaps.
Condition trackingQuality lead maintains the applicable-condition register.Named owners, status and supporting records.
Exception escalationPD or local lead brings concerns to the DI.Issue description, immediate controls and recorded decisions.
Document retrievalDocument owners maintain accessible current records.Retrieval checks and missing-record follow-up.

For suitable-practice oversight, controlled procedures can be paired with observations of work. A focused gemba walk is one practical way to compare the written method with what staff actually do. Record the activity observed, the discrepancy and the person assigned to resolve it.

Evidence should help the DI judge whether arrangements work, not merely demonstrate that documents exist. For example, an attendance record can show training occurred; an observed task assessment can help establish whether the person can perform the assigned work.

05Turn licence conditions into a controlled evidence register

HTA guidance on licence conditions distinguishes three categories: statutory conditions are set out in the Human Tissue Act and the Human Tissue (Quality and Safety for Human Application) Regulations 2007; standard conditions are applied by the HTA to all licences or a subset; additional conditions are specific to a licence. Build the register around the establishment’s applicable conditions, not a generic condition count.

As an evidence-management practice, keep three things separate: the condition’s wording, the evidence supporting it, and the internal judgement that an action is complete. The following is a recommended register structure, not an HTA-prescribed database schema.

FieldPurpose
condition_id; condition_typeStable reference and statutory, standard or additional category.
condition_text; applicable_activityExact wording and the activity to which it applies.
ownerPerson coordinating the supporting work.
due_date_if_applicableCondition-specific deadline, or a clearly labelled internal action date; otherwise blank.
evidence_referenceRetrievable document version or operational record identifier.
review_status; reviewerReview outcome and the person making that judgement.

Different records answer different questions. For an applicable storage-control condition, for example, evidence might include:

  • A procedure: what method and response were intended?
  • A competence assessment: can the assigned person perform the task?
  • A completed operational record: what actually happened, when, and with what result? A relevant temperature record could support this question; see the operational principles in temperature monitoring.

Treat task completion as a prompt for review, not proof that the condition is satisfied. The reviewer should compare the evidence with the actual wording, document gaps, and record the basis for acceptance. None of these evidence types substitutes automatically for the others.

06Manage licensing as an operational lifecycle

Use the following as a recommended internal management sequence, not a prescribed sequence of HTA application stages. Its purpose is to keep scope, evidence and accountable decisions connected as an establishment’s work changes.

  1. Define the proposed operation. Describe activities, materials, intended uses and premises together, so reviewers can assess a specific operating model rather than a broad service name.
  2. Resolve framework questions. Record uncertainties about territory, material or intended use, assign an owner and seek clarification before treating the scope assessment as settled.
  3. Confirm role holders. Identify the proposed or current Designated Individual, Licence Holder and supporting contacts. Record who reviews the evidence and who owns outstanding actions.
  4. Organise condition evidence. Connect each applicable condition to its evidence, responsible person and unresolved gaps, using the condition register described above.
  5. Track the application or variation. Keep submissions, correspondence, questions and decisions together. Distinguish preparation, submission and receipt of a decision rather than grouping them under one “complete” status.
  6. Reconcile and review. Compare actual activities and locations with the documented scope. Route discrepancies into an accountable exception process, recording the decision, action owner and closure evidence.

Keep three decisions separate: internal readiness approval records the establishment’s assessment; an HTA licensing decision is the regulator’s decision; an operational disposition decision addresses particular material or work. Do not use one as a substitute for another. A task-management status is only an internal status: people remain accountable for review and operational decisions.

Feed changed activity descriptions, changed locations, revised intended uses, role changes, unresolved discrepancies and updated conditions into management review. Use exception-based review to focus attention on unresolved issues without losing the overall scope comparison. Set review timing internally according to change and risk, rather than assuming a universal interval.

Suggested workflow: Scope → Clarify → Assign → Assemble → Track → Reconcile → Resolve exceptions ↺ Reassess scope

HTA Licence Review and Change Workflow
  1. 1
    Map activityRecord material, intended use, activity and each location.
  2. 2
    Check frameworkResolve scope questions using current legislation and HTA guidance.
  3. 3
    Assign accountabilityConfirm role holders, responsibilities and arrangements for oversight.
  4. 4
    Organise EvidenceConnect applicable conditions with procedures, competence and records.
  5. 5
    Manage authorisationTrack applications or variations separately from internal approvals.
  6. 6
    Reconcile operationsCompare recorded scope with locations, activities and material movements.
  7. 7
    Review exceptionsInvestigate discrepancies and document accountable decisions before closure.
Recommended internal controls; licensing decisions remain with the HTA.

07Connect licence scope, material movements and review evidence

Use the following as a recommended operational design, not an HTA-mandated data model. Link licence scope, role assignments, material movements, condition evidence and change cases through stable identifiers. This applies data integrity by design to the establishment’s licensing records without prescribing a particular platform.

Record categoryRecommended authoritative sourceStable links
Licence scopeControlled licence documents and variationsLicence ID, scope version, premises ID
Role assignmentsControlled appointment recordsAssignment ID, person ID, licence ID
Material movementsDesignated inventory or laboratory event recordCoded material ID, event ID, location IDs
Condition evidenceControlled evidence register and referenced documentsCondition ID, evidence ID, owner assignment
Change casesControlled change registerCase ID, affected scope version, linked records

Designate one source of truth for each category and document who maintains it. Retain the original document reference and version alongside interpreted fields such as authorised activity, condition owner and review status. A dashboard should point back to those records rather than become an independent, manually maintained account of licence scope.

Use coded material identifiers to connect inventory or laboratory records with origin, destination and movement history. Maintain consistent location mappings and material master data across interfaces. As a design recommendation, keep personal information outside routine scope dashboards wherever it is unnecessary for the review task.

Integrate inventory or laboratory systems for material and location events, document control for procedures, and training systems for competence evidence. Define which system creates each record and which systems only consume it. Include source identifiers and scope versions in exchanged records so reviewers can establish their context.

Use unique event identifiers to detect duplicate events. Route missing acknowledgements, mismatched location identifiers and stale scope versions into reconciliation queues. Preserve unresolved records and their original values rather than silently overwriting them; distinguish a transmitted event from an acknowledged, reconciled event.

For exception recovery, identify affected records, determine the authoritative source, investigate the discrepancy, reconcile linked records and obtain accountable review of closure. Record the resolution rationale and reviewer against the exception identifier.

Recommended HTA Licence Evidence Model

Licence Scope

Connect each activity and location to its authorisation.

  • licence_id
  • regulatory_framework
  • activity_description
  • premises_id
  • scope_version

Role Assignment

Record responsibility, competence evidence and documented role changes.

  • assignment_id
  • licence_id
  • person_id
  • role_type
  • competence_record_id

Material Movement

Link coded material identifiers to movement and reconciliation.

  • movement_id
  • material_id
  • from_location_id
  • to_location_id
  • reconciliation_status

Condition Evidence

Connect applicable conditions to owners and supporting records.

  • condition_id
  • licence_id
  • condition_type
  • owner_id
  • evidence_record_id

Change Case

Preserve scope decisions, exceptions and reviewed closure evidence.

  • change_id
  • licence_id
  • affected_scope_version
  • decision_record_id
  • closure_review_id
An operational record design, not a statutory reporting schema.

08Prepare for inspection through evidence retrieval and operational checks

The HTA's inspection guidance describes two patterns. Under the Human Tissue Act, site visits are conducted according to risk: some are based on the risk apparent in the completed application and others are selected at random to assess compliance. Establishments regulated under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 will be inspected at least once every two years. The HTA appoints the people who perform site visits and may delegate inspection or work with another inspectorate. Where problems are found, the HTA says it will advise how to meet the required standards; more usually it places conditions on a licence, and in extreme cases it may refuse or revoke one. The preparation exercise below is internal operational practice, not part of the HTA's procedure.

Check current HTA inspection guidance for the establishment’s sector when confirming inspection arrangements. The exercise below is recommended internal preparation, not a description of HTA inspection procedure.

  1. Select an actual activity and locate the recorded decision about its licence scope. Ask the people doing the work to explain what happens.
  2. Identify the responsible people and retrieve the evidence associated with the applicable licence conditions. Test whether another authorised colleague can locate it without relying on one person’s memory.
  3. Follow a representative material movement through its locations and records. Compare the documented process with the personnel, locations and records encountered in practice. A focused workplace observation can help structure this check.

Treat discrepancies as review inputs: a well-organised document index alone does not demonstrate that the process operates as described. Record factual observations rather than assumptions about their cause or significance.

Prepare an issue log containing the observation, affected activity or record, immediate control, accountable owner and planned verification. Keep proposed internal due dates in a separate field from any externally specified dates. Where corrective action follows, plan an effectiveness check against the observed problem.

A useful rehearsal outcome is being able to locate records and explain unresolved issues accurately, including what remains uncertain—not predicting an inspection result.

09Review licence changes and control operational shortfalls

The HTA licensing overview addresses adding activities, extending licensed premises and adding satellite sites. Treat these as prompts to consult the relevant change guidance, not as a complete procedure or a rule that every change follows the same route. Review proposed changes before implementation so unresolved scope questions remain visible.

The HTA management-structure overview describes satellite sites as small premises operating under a main establishment’s governance, supervised by the same Designated Individual (DI). Use that description to frame the scope review; it is not a numerical test for distance, floor area or staffing.

The same guidance’s licence-holder section explains that the holder has the right to apply to the HTA to vary the licence. This enables substitution of another DI when the existing DI cannot oversee licensable activities. Applying for that variation is distinct from editing an internal responsibility chart: track the licensing action separately from local role updates.

The following are suggested internal controls, not statutory notification rules. Where a shortfall is found, use the earlier recovery sequence.

Failure modePractical riskImmediate controlClosure evidence
Unmatched storage locationMaterial outside mapped scopeReconcile location against scope recordsReviewed location-to-scope mapping
Unreviewed intended-use changeWrong licensing assumptionsPause changed use pending assessmentApproved assessment and documented decision
Out-of-date role assignmentUnclear oversightEscalate to licence holder; review variation routeRole records reconciled with licensing position
Condition closed without supporting evidenceFalse assuranceReopen entry; assign evidence ownerSupporting records and reviewer sign-off

Keep an audit trail linking each change to its assessment, responsible person, correspondence and closure decision. An internal status marked “complete” should mean the reviewer can retrieve the supporting records—not merely that someone has updated a checklist.

10Three worked cases: premises, reconciliation and DI succession

These hypothetical examples illustrate internal review, not decisions about whether a real establishment is licensed. The proposed controls are operational practice, not additional legal requirements.

Case 1 — Proposed storage expansion

  • Assumptions: A project proposes three storage rooms; two match locations in the current internal scope register.
  • Evidence to inspect: Room identifiers, premises plans, the actual authorisation and current change guidance; check each room’s recorded location status.
  • Reasoning: 3 rooms − 2 matched rooms = 1 unmatched room. This identifies a review gap, not that room’s legal status.
  • Next decision: Review the unmatched room against the authorisation and guidance before deciding whether the expansion can proceed as proposed.

Case 2 — Human-application inventory discrepancy

  • Assumptions: The licensing framework is already established. A movement involves 120 vials.
  • Evidence to inspect: Dispatch, receipt and inventory records reconcile 72 vials at location A and 47 at location B.
  • Reasoning: 120 − 72 − 47 = 1 unresolved vial. A balanced total containing an unresolved item does not prove a completed movement.
  • Next decision: Keep the reconciliation case open and apply the exception process covered above.

Case 3 — DI succession

  • Assumptions: A corporate licence holder identifies a proposed successor before the current Designated Individual leaves.
  • Evidence to inspect: The successor proposal, internal handover plan, variation correspondence and current licensing record.
  • Reasoning: HTA guidance describes licence variation following an application where a DI leaves. Track the proposal, handover and licensing record separately.
  • Next decision: Apply the variation route covered above; reconcile its outcome with the licensing record rather than treating informal delegation as a completed DI change.

11Use a final review checklist and the appropriate primary resources

Use this practical checklist at a scheduled review or before an operational change. Record unresolved questions, an owner and a follow-up date; completion does not establish legal authorisation.

  • Is the activity-and-location map current, including the materials and intended uses?
  • Are framework questions resolved for the relevant territory and activity?
  • Are role records accurate and consistent with current arrangements?
  • Does each applicable licence condition have an owner and accessible evidence?
  • Are changes and reconciliation exceptions reviewed, with outstanding actions visible?
  • Can the records be retrieved coherently, from scope assessment through operational evidence to review decisions?

For record organisation, use data integrity by design principles to keep identifiers and versions consistent. An audit trail review workflow can help structure review of recorded changes. These are practical controls, not licensing tests.

  • Legislation: consult the Human Tissue Act 2004.
  • Licensing routes: use the HTA licensing hub.
  • Human-application scope questions: consult HTA Q&S licensing guidance.

Keep the resulting review record alongside the scope map and condition register, so the next reviewer can distinguish resolved questions from assumptions still needing an establishment-specific assessment.

Frequently asked questions

Q.Does an HTA Licence expire each year, and who is responsible for paying licensing fees?+

Not ordinarily. HTA guidance on licence duration and fees says licences are continuous unless otherwise agreed and remain in place until revoked. The Licence Holder should pay relevant licensing fees; the Designated Individual remains responsible for compliance with licence conditions, including those relating to fees. As an administrative practice, assign payment ownership and include outstanding fees in management review, rather than treating each invoice as a licence renewal.

Q.Does a Designated Individual have to be medically qualified?+

Not necessarily. HTA guidance on Designated Individual qualifications distinguishes the Human Tissue Act position from the Q&S Regulations, which require certain qualifications. Check the current qualification requirements for the applicable regime before selecting a candidate. As a practical appointment control, document the candidate’s qualifications, relevant experience and authority to supervise the proposed activities, using attributable recording to identify who assessed and approved the appointment.

Q.What can a Person Designated do, and why is a visiting pathologist not normally named as one?+

The HTA’s Person Designated guidance describes a supplementary governance role: the PD can direct licensable activities and support the DI locally, while the DI retains supervisory responsibility. A visiting pathologist would rarely occupy that governance position, so is not normally named. In practice, document the PD’s local remit against the relevant operations, and use contemporaneous recording for instructions or interventions rather than relying on an informal job-title assumption.

Q.Why does the HTA prefer a corporate licence holder where possible?+

The preference supports continuity of oversight. HTA licence-holder guidance explains that the Licence Holder can apply to vary the licence to substitute another DI when the existing DI cannot oversee activities. It prefers a corporate holder, such as an NHS Trust, with a representative senior to the DI. As a governance practice, record DI absence and succession arrangements in the quality risk register, including who initiates the variation request.

Q.What opportunity is there to respond when the HTA imposes conditions on a licence?+

HTA guidance on imposing licence conditions says it must give written notice to the DI and, if different, the Licence Holder, with an opportunity to make representations within 28 days of notification. As a response-management practice, log receipt, assign an owner and distinguish factual corrections from proposed remedial actions. Relevant deviation records and an audit trail review workflow can help organise the supporting chronology without replacing the written response.

Q.Does every research tissue store need a licence, or should an exemption be checked?+

Check whether an exemption applies rather than assuming every research store needs the same licensing arrangement. The HTA’s Human Tissue Act licensing overview identifies storage for scheduled purposes among licensed activities and points to specific licensing exemptions. Check the current exemption criteria against the actual project. As a practical scope record, list the material, purpose, premises and proposed exemption basis; use location status to distinguish assessed storage locations from those awaiting a decision.

Q.How should a project involving both Scottish and English, Welsh or Northern Irish premises organise its scope assessment?+

Assess each premises separately. The HTA’s territorial overview says the Human Tissue Act primarily covers England, Wales and Northern Ireland; only section 45 and Schedule 4 include Scotland, which has separate legislation. For project planning, build a site-by-activity matrix covering material, purpose and whether human application is involved. Consistent material master data and production context tagging can help manufacturing teams keep those site-specific assessments attached to the correct activities.

Q.Can an existing manufacturing quality-management system help organise HTA licence records?+

Yes—as an organisational practice, an existing QMS can provide a structure for licence documents, role assignments, correspondence, training records and change assessments. Review whether its record types and permissions fit the tissue activities rather than simply reusing manufacturing templates. An audit trail can preserve change history, while MES–QMS integration may connect operational records with quality review. Software does not establish legal compliance or confer licensing authority; approval and release decisions remain with authorised people.

Primary sources

  • HTA Licensing
  • HTA What is an HTA licence
  • HTA How licensing works under the Human Tissue Act
Software that covers HTA Licence
V5 Ultimate Tissue Bank Software
V5 provides lot status, recorded movements, configured processing steps and linked lab samples. Confirm how your HCT/P…
Talk to us about HTA Licence

Want to see how HTA Licence could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Where this term comes up
Blood & Tissue
Inside V5
  • → Document control — one version in force, every change signed and explained.
  • → QMS — quality records next to the work they concern.
  • → 21 CFR Part 11 — signatures and audit history your team can validate.
Example reports
V5Ultimate

Sample report

Compliance Readiness Assessment

Quality system

Compliance Readiness AssessmentView on screen or print
V5Ultimate

Sample report

Validation Support Pack

Quality system

Validation Support PackView on screen or print
→ All example reports
Regulatory anchors
  • Human Tissue Act 2004
  • HT (Quality and Safety for Human Application) Regulations 2007
  • EU Directive 2004/23/EC
Related terms
  • → 21 CFR 1271
  • → BSQR 2005
  • → Chain of Custody
  • → ISBT 128
  • → AABB Standards

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC